Aman Agarwal

Aman Agarwal

Auto-generated profile, based on publicly available information

Aman Agarwal

Maulana Azad Medical College, New Delhi, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
HPHinal Rd Year Mbbs Patel
Hinal Rd Year Mbbs Patel
RKRavneet Kaur
Ravneet Kaur
MAMohammad Haris Ali
Mohammad Haris Ali
ZHZeenat Graduated Hadi
Zeenat Graduated Hadi
APAnushri Final Year Student(Mbbs) Parikh
Anushri Final Year Student(Mbbs) Parikh
Md. Al HasibuzzamanMd. Al Hasibuzzaman
Md. Al Hasibuzzaman
Background: Diarrhea is a prevalent condition affecting millions worldwide. However, current standard diagnostic methods have many drawbacks. This review examines various non-invasive point-of-care (POC) tests and biomarkers aiding rapid diagnosis of diarrhea from different causes. Methods: PubMed, PubMed Central, ScienceDirect, Cochrane Library, and Google Scholar were searched from 2013 to present for relevant literature. Two reviewers independently assessed included studies’ quality using the Critical Appraisal Skills Programme (CASP) checklist. Results: The search yielded 1453 studies, of which 39 were included after screening and applying eligibility criteria. Polymerase chain reaction (PCR) was the POC test in 25 studies, providing consistent sensitivity and specificity. For biomarkers, C-reactive protein (CRP), fecal calprotectin, and procalcitonin offered high sensitivity and specificity for conditions like acute pediatric diarrhea, microscopic colitis, and inflammatory diarrhea, respectively. Conclusion: PCR proved the ideal POC test for rapid diarrhea diagnosis, while the procalcitonin biomarker helps differentiate inflammatory from non-inflammatory diarrhea. Other reviewed tools also demonstrated promising diagnostic performance, though improvements in sensitivity, specificity, and usability are still needed.

9 July 2024 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
SASukriti Asija
Sukriti Asija
BPBhavya Pahwa
Bhavya Pahwa
AAAman Agarwal
Aman Agarwal
YPYogeshwari Patil
Yogeshwari Patil
BCBipin Chaurasia
Bipin Chaurasia

27 March 2025 in Cardiology in Review
Verified
Journal Article
Closed access
AAAman Agarwal
Aman Agarwal
SASrishty Mbbs Agarwal
Srishty Mbbs Agarwal
MHMohammad Mbbs Hazique
Mohammad Mbbs Hazique
LBLavanya Bansal
Lavanya Bansal
HBHimanshi Mbbs Banker
Himanshi Mbbs Banker
RJRohit Jain
Rohit Jain
Periodontal disease is a chronic inflammatory condition that affects the tissues that support the teeth. It has been linked with various systemic conditions such as cardiovascular disorders, respiratory conditions, and diabetes, reinforcing the concept of oral-systemic hygiene. With its high prevalence and significant economic burden, periodontal disease has become a critical public health concern, impacting 11.2% of the global adult population. This article aims to discuss the association between periodontal disease and the mechanisms leading to the development of myocardial infarction (MI). This condition occurs due to ischemia of heart muscle tissue from lack of blood supply for a prolonged period, which further leads to systolic dysfunction, metabolic derangements, and cellular death. Several studies have discovered a link between MI and dental disorders, raising the possibility that inflammation brought on by periodontitis may increase cardiovascular risk. Bacterial translocation, endotoxins from gram-negative pathogens, cytokines, and platelet activation are the major players leading to severe inflammatory conditions that influence the progression of atherosclerosis, further leading to MI. Autoimmune processes with homologous heat shock proteins from bacterial pathogens also trigger cellular and humoral immune responses, linking periodontal diseases and MI. Since periodontal disease may serve as a modifiable risk factor for MI, public health needs to comprehend the relationship between oral health and MI. Recent studies have identified the need to look for biomarkers that may correlate with the aforementioned health conditions, laying greater emphasis on the development of standardized protocols for risk mitigation and the need for tailored therapies.

24 June 2024 in Precision Medical Sciences
Verified
Journal Article
Open access
AAAman Agarwal
Aman Agarwal
RKRavneet Kaur
Ravneet Kaur
FAFaiza Ashfaque
Faiza Ashfaque
ZHZeenat Hadi
Zeenat Hadi
MAMuhammad Wajeeh Anis
Muhammad Wajeeh Anis
Md. Al HasibuzzamanMd. Al Hasibuzzaman
Md. Al Hasibuzzaman
Epilepsy is one of the most common neurological diseases globally. We conducted a systematic review of the genetic markers and personalized treatment strategies used in the precision medicine treatment of epilepsy. An exhaustive electronic search was carried out on PubMed and Google Scholar, spanning from inception up to June 2023 on epilepsy and biomarkers. A total of 45 articles from PubMed and 19 articles from Google Scholar were imported and screened based on studies that focused primarily on genetic markers and precision methods for epilepsy subtyping, treatment strategies, outcomes, and adverse effects. Reviews and studies not in English were excluded. Full‐text data extraction, coding, and analysis were carried out with Microsoft Excel. For the risk of bias assessment of the final included studies, the Critical Appraisal Skills Program checklist was used. A total of 19 studies were analyzed in the review. The SLC35A2 gene saw a reduction in seizure frequency with d‐galactose treatment while the KCNQ2 gene saw improvement with phenytoin, carbamazepine, and retigabine. GRIN2D gene saw varying improvements with memantine. KCNT1 gene saw improvement with only a combination of quinidine and topiramate, quinidine was not useful when used alone. Other studies involved the identification of different markers using gene and exome sequencing. These studies collectively provide a diverse range of insights into epilepsy, with variations in study design, sample size, age groups, and diagnostic criteria, highlighting the multifaceted nature of epilepsy research. These studies contribute to our understanding of epilepsy diagnosis and management in different clinical settings, however, there were some limitations such as QT prolongation was observed with specific medications and participant heterogeneity. Small sample sizes reduced statistical power and brief durations of studies limited their ability for long‐term analysis. Although most studies had a low risk of bias, two studies demonstrated some reporting bias. Fianlly, the absence of biomarkers is a limitation that impedes the study's capacity to explore underlying biological mechanisms.

2 January 2024 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
ASAnju Sharma
Anju Sharma
VMVikas Manchanda
Vikas Manchanda
AAAman Agarwal
Aman Agarwal
AKAdvitiya Kapoor
Advitiya Kapoor
SKSunil Kumar
Sunil Kumar
SSSonal Saxena
Sonal Saxena

28 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
SPSuhrud J. Panchawagh
Suhrud J. Panchawagh
PKPratyush Kumar
Pratyush Kumar
SSShabarini Srikumar
Shabarini Srikumar
KPKhushi Prajapati
Khushi Prajapati
MSManali Sarkar
Manali Sarkar
PSPoorvikha S
Poorvikha S
Leptin is a peptide hormone synthesized by white adipose tissue. Its principal site of action is in the brainstem and hypothalamus, where it acts to modulate satiety and control of reward and aversion. Leptin deficiency or resistance is associated with dysregulation of cytokine production, increased susceptibility to infections, autoimmune disorders, malnutrition, and inflammatory responses. Studies have shown variation in leptin levels between males and females, and in different phases of the menstrual cycle as well. Our study aims to explain the variation in leptin levels and their physiological role in the menstrual cycle. A total of 1887 records were identified from PubMed, Google Scholar, and Cochrane. We included studies where females were 18-40 years of age, who had achieved menarche, and were on regular menstrual cycles. We excluded studies which were cross-section, pre-prints, or studies where inadequate information was provided. Seven studies were included in the study. We used the standardized mean difference as the outcome measure. Leptin levels varied significantly in the phases of the menstrual cycle as well as during prepubertal, pubertal, and postpubertal phases. The standardized mean difference in leptin levels between the follicular phase and the luteal phase was 2.67 ng/mL (95% CI: 0.16 to 5.19 ng/mL). Fluctuations in leptin levels can cause weight changes and reproductive cycle disturbances. Hence, in cases of infertility with abnormal menstrual cycles, measurement of the physiologic variability in leptin levels may help to diagnose the cause of infertility and appropriate interventions can be started.